Close

Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/Year

September 19, 2016 4:13 PM EDT Send to a Friend
Sarepta Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login